Skip to content

Effects of Dexmedetomidine on OI, RI and Inflammatory Factors in Patients Undergoing Palatopalatyngoplasty.

Effects of Dexmedetomidine on Oxygenation Index, Respiratory Index and Inflammatory Factors in Patients Undergoing Palatopalatyngoplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03612440
Enrollment
80
Registered
2018-08-02
Start date
2018-08-01
Completion date
2019-04-30
Last updated
2018-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effect

Keywords

dexmedetomidine, oxygenation index, respiratory index, inflammatory factors

Brief summary

The purpose of this study is to investigate the efficacy of dexmedetomidine on oxygenation index, respiratory index and inflammatory factors, and to explore the protective effect of the dexmedetomidine on respiratory function in patients undergoing palatopalatyngoplasty.

Detailed description

Obstructive sleep apnea syndrome is common among people, especially among obese people, Which is characterized by periodic or complete upper airway obstruction and hypoxia during sleep. Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation. Some researchers suggested that dexmedetomidine can inhibit inflammatory reaction and lessen the damage of respiratory function. The aim of this study is to investigate the efficacy of dexmedetomidine on oxygenation index, respiratory index and inflammatory factors, and to explore the protective effect of the dexmedetomidine on respiratory function in patients undergoing palatopalatyngoplasty.

Interventions

DRUGdexmedetomidine

receive a loading infusion of dexmedetomidine (1ug/kg)for 20min follow by a maintenance infusion (0.4ug/kg/h) continued until the end of the surgery

OTHERnormal saline

receive matching placebo (equal volum of normal saline)

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing palatopalatyngoplasty * ASA physical status II-III * Aged 18-65 years * BMI 18.5-30kg/m2

Exclusion criteria

* Bradycardia * Atrioventricular block * Allergic to the drugs * Complicating pulmonary disease(including pulmonary infection,COPD, asthma and so on)

Design outcomes

Primary

MeasureTime frameDescription
The Oxygenation IndexIntraoperative and immediately after surgeryArterial blood samples were sampled before anaesthesia induction and immediately after surgery for the oxygenation index by using blood gas analyzer.
The Respiratory IndexIntraoperative and immediately after surgeryArterial blood samples were sampled before anaesthesia induction and immediately after surgery for the respiratory index by using blood gas analyzer.

Secondary

MeasureTime frameDescription
Change of tumor necrosis factor-α before anesthesia and immediately after surgeryIntraoperative and immediately after surgeryBlood samples were sampled before anaesthesia induction and immediately after surgery for the serum tumor necrosis factor-α,which were analyzed by using enzyme linked immunosorbent assay (ELISA).
Change of interleukin-6 before anesthesia and immediately after surgeryIntraoperative and immediately after surgeryBlood samples were sampled before anaesthesia induction and immediately after surgery for the serum interleukin-6, which were analyzed by using enzyme linked immunosorbent assay (ELISA).
Change of interleukin-10 before anesthesia and immediately after surgeryIntraoperative and immediately after surgeryBlood samples were sampled before anaesthesia induction and immediately after surgery for the serum interleukin-10, which were analyzed by using enzyme linked immunosorbent assay (ELISA).

Countries

China

Contacts

Primary ContactMa Hanxiang
mahanxiang@hotmail.com+86-13519591508
Backup ContactLi Na
+86-13629517998

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026